Alaunos Therapeutics Inc. (TCRT)
Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
2. 21
+0.24
+12.1827%
$
4.86M Market Cap
- P/E Ratio
- Div Yield
19,989 Volume
-0.6 Eps
$ 1.97
Previous Close 
Want to track TCRT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alaunos Therapeutics Inc. (TCRT) Statistics
Valuation metrics
Market Cap 4.86M
Enterprise value 5.21M
Trailing P/E (ttm) -1.08
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) 1,856.03
Price/Book (mrq) 3.45
Enterprise Value/Revenue 1,738.03
Enterprise Value/EBITDA -1.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 42.59K
Average volume (90 days) 14.8K
Price summary
52-Week low 1.67
52-Week high 6.2
Beta -
50-Day moving average 2.59
200-Day moving average 3.05
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 18 Jul 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1,369.67%
Operating margin -1,381.67%
Operational effectiveness
Return on assets -2.18%
Return on equity -1.66%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.18
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.63%
Book value per share (mrq) 0.66
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
